ATE348803T1 - Tryptase-inhibitoren - Google Patents
Tryptase-inhibitorenInfo
- Publication number
- ATE348803T1 ATE348803T1 AT02740716T AT02740716T ATE348803T1 AT E348803 T1 ATE348803 T1 AT E348803T1 AT 02740716 T AT02740716 T AT 02740716T AT 02740716 T AT02740716 T AT 02740716T AT E348803 T1 ATE348803 T1 AT E348803T1
- Authority
- AT
- Austria
- Prior art keywords
- tryptase inhibitors
- inhibitors
- tryptase
- meanings
- compounds
- Prior art date
Links
- 239000002750 tryptase inhibitor Substances 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/04—Drugs for disorders of the respiratory system for throat disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pulmonology (AREA)
- Urology & Nephrology (AREA)
- Neurosurgery (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Immunology (AREA)
- Dermatology (AREA)
- Biomedical Technology (AREA)
- Otolaryngology (AREA)
- Neurology (AREA)
- Ophthalmology & Optometry (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP01114642 | 2001-06-19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE348803T1 true ATE348803T1 (de) | 2007-01-15 |
Family
ID=8177746
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02740716T ATE348803T1 (de) | 2001-06-19 | 2002-06-14 | Tryptase-inhibitoren |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US6962941B2 (de) |
| EP (1) | EP1401809B1 (de) |
| JP (1) | JP2005508871A (de) |
| AT (1) | ATE348803T1 (de) |
| AU (1) | AU2002314165B2 (de) |
| CA (1) | CA2450659A1 (de) |
| DE (1) | DE60216920T2 (de) |
| ES (1) | ES2278928T3 (de) |
| WO (1) | WO2002102771A1 (de) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI504597B (zh) * | 2006-03-16 | 2015-10-21 | Pharmascience Inc | 結合於細胞凋亡抑制蛋白（ｉａｐ）之桿狀病毒ｉａｐ重複序列（ｂｉｒ）區域之化合物 |
| JP2011057596A (ja) * | 2009-09-09 | 2011-03-24 | Ichimaru Pharcos Co Ltd | トリプターゼ活性阻害剤およびその利用 |
| CN110437307B (zh) * | 2019-07-26 | 2020-11-13 | 暨南大学 | 一类具抗血栓和脑神经细胞保护作用的水蛭多肽及其应用 |
| CN115784960A (zh) * | 2022-12-07 | 2023-03-14 | 华南理工大学 | 一种s-亚硝基谷胱甘肽还原酶抑制剂n6022中间体及其合成方法 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2764495A (en) | 1994-06-01 | 1995-12-21 | Arris Pharmaceutical Corporation | Compositions and methods for treating mast-cell mediated conditions |
| PL183552B1 (pl) | 1994-09-23 | 2002-06-28 | Axys Pharmaceuticals | Nowe związki cykliczne i środek farmaceutyczny |
| EE9900036A (et) | 1996-07-30 | 1999-08-16 | Arris Pharmaceutical Corporation | Uued ühendid ja kompositsioonid trüptaasi aktiivsusega seotud haiguste raviks |
| WO1999012918A1 (en) | 1997-09-05 | 1999-03-18 | Yoshitomi Pharmaceutical Industries, Ltd. | Tryptase inhibitor |
| AU1208999A (en) | 1997-11-10 | 1999-05-31 | Array Biopharma, Inc. | Compounds which inhibit tryptase activity |
| US6221914B1 (en) | 1997-11-10 | 2001-04-24 | Array Biopharma Inc. | Sulfonamide bridging compounds that inhibit tryptase activity |
| US6489327B1 (en) * | 1998-02-06 | 2002-12-03 | Max-Planck-Gesellschaft Zur Fordrungder Wisenschaften, E.V. | Tryptase inhibitors |
| EP1060171A2 (de) * | 1998-02-06 | 2000-12-20 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Tryptase-inhibitoren |
| EP1115731A2 (de) | 1998-09-04 | 2001-07-18 | Byk Gulden Lomberg Chemische Fabrik GmbH | Neue pyranosen |
| DE19937721A1 (de) | 1999-08-10 | 2001-02-15 | Max Planck Gesellschaft | Neue Diketopiperazine |
| KR20020016942A (ko) | 1999-08-10 | 2002-03-06 | 빅 굴덴 롬베르크 케미쉐 파브릭 게엠베하 | 디아조신-디온 유도체 및 이것의 트립타제 억제제로서 용도 |
| AU778965B2 (en) * | 1999-09-14 | 2004-12-23 | Altana Pharma Ag | Tryptase inhibitors |
| AU783217B2 (en) | 1999-12-20 | 2005-10-06 | Altana Pharma Ag | Tryptase inhibitors |
| CA2392127A1 (en) | 1999-12-20 | 2001-06-28 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Tryptase inhibitors |
| ES2225758T3 (es) | 2001-01-31 | 2005-03-16 | Altana Pharma Ag | Derivdos de diazocina y su uso como agentes inhibidores de la triptasa. |
| JP2004518735A (ja) | 2001-02-21 | 2004-06-24 | アルタナ ファルマ アクチエンゲゼルシャフト | トリプターゼインヒビター |
| EP1368317B1 (de) | 2001-02-21 | 2006-12-27 | Altana Pharma AG | Tryptaseinhibitoren |
| AU2002254941B2 (en) | 2001-03-15 | 2007-05-17 | Altana Pharma Ag | Tryptase-inhibitors |
-
2002
- 2002-06-14 CA CA002450659A patent/CA2450659A1/en not_active Abandoned
- 2002-06-14 AU AU2002314165A patent/AU2002314165B2/en not_active Ceased
- 2002-06-14 ES ES02740716T patent/ES2278928T3/es not_active Expired - Lifetime
- 2002-06-14 WO PCT/EP2002/006537 patent/WO2002102771A1/en not_active Ceased
- 2002-06-14 EP EP02740716A patent/EP1401809B1/de not_active Expired - Lifetime
- 2002-06-14 US US10/480,925 patent/US6962941B2/en not_active Expired - Fee Related
- 2002-06-14 AT AT02740716T patent/ATE348803T1/de not_active IP Right Cessation
- 2002-06-14 JP JP2003505314A patent/JP2005508871A/ja not_active Withdrawn
- 2002-06-14 DE DE60216920T patent/DE60216920T2/de not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| DE60216920T2 (de) | 2007-11-15 |
| EP1401809A1 (de) | 2004-03-31 |
| CA2450659A1 (en) | 2002-12-27 |
| JP2005508871A (ja) | 2005-04-07 |
| ES2278928T3 (es) | 2007-08-16 |
| US6962941B2 (en) | 2005-11-08 |
| US20040176421A1 (en) | 2004-09-09 |
| AU2002314165B2 (en) | 2008-02-21 |
| DE60216920D1 (en) | 2007-02-01 |
| WO2002102771A1 (en) | 2002-12-27 |
| EP1401809B1 (de) | 2006-12-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60310576D1 (en) | 2-hydroxy-6-phenylphenanthridine als pde-4-hemmer | |
| IS7721A (is) | Píperidín-pýrídasón og þalasón sem PDE4 hemlar | |
| ATE353217T1 (de) | 3-hydroxy-6-phenylphenanthridine als pde-4 inhibitoren | |
| HRP20050228A2 (en) | Novel phenanthridines | |
| EA201100689A1 (ru) | N-сульфонилпирролы и их применение в качестве ингибиторов гистондезацетилазы | |
| MX2007005408A (es) | Compuestos de aminoquinazolinas. | |
| ES2186874T3 (es) | Analogos de m-amidinofenilo como inhibidores del factor xa. | |
| EA200601587A1 (ru) | Новые амидозамещённые гидрокси-6-фенилфенантридины | |
| ATE275544T1 (de) | Serinprotease-inhibitoren | |
| TW200600499A (en) | Novel amido-substituted hydroxy-6-phenylphenanthridines | |
| TR200201128T2 (tr) | PDE4 inhibitörleri olarak tetrahidrotiyopiranfitalazinon türevleri. | |
| ATE287403T1 (de) | 6-phenylbenzonaphthyidine | |
| ATE269313T1 (de) | Tryptase-inhibitoren | |
| DK1244614T3 (da) | Tryptase-inhibitorer | |
| ATE348803T1 (de) | Tryptase-inhibitoren | |
| ATE364037T1 (de) | Tryptasehemmer | |
| DK1358182T3 (da) | Diazocin-derivater og anvendelsen deraf som tryptase-inhibitorer | |
| ATE508130T1 (de) | 3-oxa-10-aza-phenanthrene als pde4- oder pde3/4- inhibitoren | |
| ATE328883T1 (de) | Imidazopyridin-8-one | |
| SG145571A1 (en) | Intermediates useful in the synthesis of hiv-protease inhibitors and methods for preparing the same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |